Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 0 075 versus MAGNESIUM SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 45 AND POTASSIUM CHLORIDE 0 075 versus MAGNESIUM SULFATE.
DEXTROSE 5%, SODIUM CHLORIDE 0.45% AND POTASSIUM CHLORIDE 0.075% vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose supplies glucose for cellular metabolism, restoring blood glucose levels and providing calories. Sodium chloride and potassium chloride replace electrolytes to maintain fluid and electrolyte balance.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion; typical rate 100-200 mL/hour for maintenance or as directed by clinical condition, not to exceed 25 mL/kg/hour.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Dextrose: ~15-20 min for exogenous glucose in normoglycemic states, but insulin-dependent; potassium: ~12-24 hours for total body potassium turnover, but clinical context is distributional; sodium and chloride: large body pools, no defined half-life in this context.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Renal: Dextrose (glucose) is reabsorbed in proximal tubules; excess is excreted unchanged in urine. Sodium and potassium are primarily excreted renally, with potassium secretion in distal nephron; chloride follows sodium. No significant biliary or fecal elimination.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte